Stoke Therapeutics Inc (NASDAQ:STOK) shares are rising in Tuesday’s after-hours session, riding a wave a momentum higher despite announcing a proposed public offering after the bell. What To Know: After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a 30-day window to purchase up to an additional 15% of the shares in the public offering. Stoke said it expects to use the net proceeds to fund research, clinical and process development and manufacturing o…